Amanda Bergner completed her genetic counseling graduate education at the University of California, Berkeley. She is a diplomate of the American Board of Genetic Counseling and has been involved in graduate-level education of genetic counseling, medical and nursing students for the past 17 years. Ms. Bergner is active within the broader field of genetic counseling. She is currently the President of the Accreditation Council for Genetic Counseling and an author for the forthcoming Neurofibromatosis Practice Resource and Epilepsy Genetic Testing Practice Guideline. Additionally, she has maintained a busy clinical practice through the years – first at UCSF in biochemical genetics, then at Johns Hopkins in general genetics and neurogenetics, and now at Columbia New York Presbyterian Hospital. Her research has focused primarily on elucidating the experience of individuals and families living with neurogenetic disorders, addressing topics such as measures of quality of life, the use of patient-reported outcome measures as endpoints for therapeutic clinical trials, and the use of mobile technology to support communication.